Inhibition of NF-κB decreased inducible nitric oxide synthase and cyclooxygenase-2 expression and restored working memory in the Alzheimer's disease mouse model [30]. The gene discussed is NFKB1; the disease is early-onset autosomal dominant Alzheimer disease.